Profound Medical Corp. Files 8-K on Financials
Ticker: PROF · Form: 8-K · Filed: Oct 7, 2025 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 8-K |
| Filed Date | Oct 7, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Profound Medical Corp. filed an 8-K on Oct 7, 2025, detailing financial results and condition.
AI Summary
Profound Medical Corp. filed an 8-K on October 7, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario, Canada.
Why It Matters
This 8-K filing provides an update on Profound Medical Corp.'s financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or negative developments.
Key Players & Entities
- Profound Medical Corp. (company) — Registrant
- October 7, 2025 (date) — Date of Report
- 2400 Skymark Avenue, Unit 6, Mississauga, Ontario, Canada (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filing submitted?
The filing was submitted on October 7, 2025.
What is the principal business address of Profound Medical Corp.?
The principal executive offices are located at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario, Canada.
What is the Standard Industrial Classification code for Profound Medical Corp.?
The SIC code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
What is the Commission File Number for Profound Medical Corp.?
The Commission File Number is 001-39032.
Filing Stats: 527 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-10-07 08:06:42
Filing Documents
- f8k_100725.htm (8-K) — 15KB
- exh_991.htm (EX-99.1) — 9KB
- 0001171843-25-006317.txt ( ) — 221KB
- gnw-20250101.xsd (EX-101.SCH) — 3KB
- gnw-20250101_def.xml (EX-101.DEF) — 25KB
- gnw-20250101_lab.xml (EX-101.LAB) — 35KB
- gnw-20250101_pre.xml (EX-101.PRE) — 24KB
- f8k_100725_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On October 7, 2025, Profound Medical Corp. (the "Company") issued a press release to announce certain of its preliminary unaudited financial results for the three months ended September 30, 2025 and provided a business update. A copy of the press release is furnished as Exhibit 99.1. The information in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be "filed" for purposes of Section 18, of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section, and shall not be deemed to be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated October 7, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROFOUND MEDICAL CORP. Date: October 7, 2025 By: /s/ Rashed Dewan Rashed Dewan Chief Financial Officer